Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients

DNA Methylation of ADME Genes

(2016) P Fisel et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population

(2015) Q Xu et al.   PHARMACOGENOMICS JOURNAL

Association studies of cytochrome P450, family 2, subfamily E, polypeptide 1 (CYP2E1) gene polymorphisms with acute rejection in kidney transplantation recipients

(2014) Su Kang Kim et al.   CLINICAL TRANSPLANTATION

Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver

(2014) Wanqing Liu et al.   HUMAN MOLECULAR GENETICS

Exploring the roles of UGT1A1 and UGT1A3 in oral clearance of GSK2190915, a 5-lipoxygenase-activating protein inhibitor

(2014) Michael Mosteller et al.   Pharmacogenetics and Genomics

Histamine H4 Receptor Polymorphism

(2013) Zhiyun Wei et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

(2013) Ulrich M. Zanger et al.   PHARMACOLOGY & THERAPEUTICS

DNA methylation dynamics in the hepatic CYP3A4 gene promoter

(2012) Marina Kacevska et al.   BIOCHIMIE

Epigenomics and Interindividual Differences in Drug Response

(2012) M Ivanov et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Epigenetic-dependent regulation of drug transport and metabolism: an update

(2012) Marina Kacevska et al.   PHARMACOGENOMICS

Genetic Polymorphisms in CYP2E1: Association with Schizophrenia Susceptibility and Risperidone Response in the Chinese Han Population

(2012) Ran Huo et al.   PLoS One

Association between a COMT polymorphism and clinical response to risperidone treatment

(2012) Qing-Zhu Zhao et al.   PSYCHIATRIC GENETICS

Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood

(2012) Matthew N Davies et al.   GENOME BIOLOGY

Perspectives on Epigenetics and Its Relevance to Adverse Drug Reactions

(2011) M Kacevska et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone

(2010) Nikolina Jovanović et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Uridine 5´-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy

(2010) Jacqueline Ramírez et al.   Future Oncology

Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in Chinese Han populations from four different geographic areas of Mainland China

(2010) Kefu Tang et al.   GENOMICS

The environment and schizophrenia

(2010) Jim van Os et al.   NATURE

Identification of Novel Candidate Genes for Treatment Response to Risperidone and Susceptibility for Schizophrenia: Integrated Analysis Among Pharmacogenomics, Mouse Expression, and Genetic Case-Control Association Approaches

(2009) Masashi Ikeda et al.   BIOLOGICAL PSYCHIATRY

Pharmacoepigenetics: Its Role in Interindividual Differences in Drug Response

(2009) A Gomez et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Human UGT1A3 Enzyme Conjugates Norursodeoxycholic Acid into a C23-ester Glucuronide in the Liver

(2009) Jocelyn Trottier et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients

(2009) J. Du et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment

(2009) Meenal Gupta et al.   PHARMACOGENOMICS

Functional Polymorphism of the Human Multidrug Resistance Gene (MDR1) and Polydipsia–Hyponatremia in Schizophrenia

(2008) Takahiro Shinkai et al.   NEUROMOLECULAR MEDICINE